Clinical trial
Open-Label, Uncontrolled, Multicenter, Phase II Study Evaluating the Efficacy and Safety of Cetuximab in Combination With Cisplatin & Gemcitabine as First-Line Therapy in Patients With Advanced Non Small Cell Lung Cancer
NCT00561054 is registered in ClinicalTrials.gov with Grupo Portugues de Estudo do Cancro do Pulmao as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-Label, Uncontrolled, Multicenter, Phase II Study Evaluating the Efficacy and Safety of Cetuximab in Combination With Cisplatin & Gemcitabine as First-Line Therapy in Patients With Advanced Non Small Cell Lung Cancer
- Lead sponsor
- Grupo Portugues de Estudo do Cancro do Pulmao
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- March 31, 2007
- Completion date
- Not reported
- Enrollment
- 47 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.